Gessel advised WSE-listed Bioceltix S.A. on the deal.Bioceltix S.A. executed a non-brokered public offering of the Company’s shares carried out under the accelerated book-building (ABB) procedure and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
